US 7618623
Hybrid adeno-retroviral vector for the transfection of cells
granted A61KA61K35/13A61K48/00
Quick answer
US patent 7618623 (Hybrid adeno-retroviral vector for the transfection of cells) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K35/13, A61K48/00, A61P, A61P43/00